Literature DB >> 22402855

Neuromyelitis optica and pregnancy.

B Bourre1, R Marignier, H Zéphir, C Papeix, D Brassat, G Castelnovo, N Collongues, S Vukusic, P Labauge, O Outteryck, B Fontaine, P Vermersch, C Confavreux, J de Seze.   

Abstract

OBJECTIVE: The purpose of our study was to assess the influence of pregnancy on the course of neuromyelitis optica (NMO) and the impact of epidural analgesia and breastfeeding on its activity in the postpartum period.
METHODS: We performed a retrospective study of patients with NMO diagnosed according to Wingerchuk criteria. We noted the number of relapses during the year before pregnancy (BP), during pregnancy (first trimester, second trimester, third trimester), and the year after (Y + 1: first trimester, second trimester [PP2], and third and fourth trimesters postpartum). Epidural analgesia and breastfeeding were recorded. Disability was evaluated with the Kurtzke Expanded Disability Status Scale (EDSS). The annualized relapse rate (ARR) was calculated.
RESULTS: We identified 124 patients (85 female) in the French NOMADMUS cohort on November 1, 2010. A total of 20 women (including 25 pregnancies) were informative with complete files. Comparisons between the ARR of each period and BP (1.0 ± 0.09) only showed an increased tendency for PP2 (0.8 ± 0.06, p = 0.07). Epidural analgesia and breastfeeding had no influence on the course of NMO. The EDSS score increased from 1.5 ± 1.7 BP to 2.6 ± 1.9 Y + 1 (p = 0.027).
CONCLUSION: This study shows that pregnancy influences the activity of NMO, a finding that justifies close medical monitoring. We found no evidence to suggest that either epidural analgesia or breastfeeding has an aggravating effect on NMO.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22402855     DOI: 10.1212/WNL.0b013e31824c466f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  36 in total

Review 1.  Aquaporin 4 and neuromyelitis optica.

Authors:  Marios C Papadopoulos; A S Verkman
Journal:  Lancet Neurol       Date:  2012-05-16       Impact factor: 44.182

Review 2.  Common and Rare Manifestations of Neuromyelitis Optica Spectrum Disorder.

Authors:  Dominique Rosales; Ilya Kister
Journal:  Curr Allergy Asthma Rep       Date:  2016-06       Impact factor: 4.806

Review 3.  Treatment of neuromyelitis optica: state-of-the-art and emerging therapies.

Authors:  Marios C Papadopoulos; Jeffrey L Bennett; Alan S Verkman
Journal:  Nat Rev Neurol       Date:  2014-08-12       Impact factor: 42.937

4.  Neurologic diseases in women: Five new things.

Authors:  Mary Angela O'Neal
Journal:  Neurol Clin Pract       Date:  2013-06

Review 5.  Multiple sclerosis and pregnancy in the 'treatment era'.

Authors:  Sandra Vukusic; Romain Marignier
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

Review 6.  Headache in Neuromyelitis Optica.

Authors:  Alina Masters-Israilov; Matthew S Robbins
Journal:  Curr Pain Headache Rep       Date:  2017-04

7.  Neuromyelitis optica and pregnancy.

Authors:  Yára Dadalti Fragoso; Tarso Adoni; Denis Bernardi Bichuetti; Joseph Bruno Bidin Brooks; Maria Lucia Brito Ferreira; Enedina Maria Lobato Oliveira; Celso Luis Silva Oliveira; Sonia Beatriz Felix Ribeiro; Alex Eduardo Silva; Fabio Siquineli
Journal:  J Neurol       Date:  2013-07-09       Impact factor: 4.849

8.  High risk of postpartum relapses in neuromyelitis optica spectrum disorder.

Authors:  Eric C Klawiter; Riley Bove; Liene Elsone; Enrique Alvarez; Nadja Borisow; Melissa Cortez; Farrah Mateen; Maureen A Mealy; Jaime Sorum; Kerry Mutch; Sean M Tobyne; Klemens Ruprecht; Guy Buckle; Michael Levy; Dean Wingerchuk; Friedemann Paul; Anne H Cross; Anu Jacobs; Tanuja Chitnis; Brian Weinshenker
Journal:  Neurology       Date:  2017-11-01       Impact factor: 9.910

9.  Sex and gender issues in multiple sclerosis.

Authors:  Hanne F Harbo; Ralf Gold; Mar Tintoré
Journal:  Ther Adv Neurol Disord       Date:  2013-07       Impact factor: 6.570

Review 10.  Neuromyelitis optica spectrum disorders and pregnancy: relapse-preventive measures and personalized treatment strategies.

Authors:  Nadja Borisow; Kerstin Hellwig; Friedemann Paul
Journal:  EPMA J       Date:  2018-08-10       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.